News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Biotage AB: Interim Report January - September 2010
October 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
STOCKHOLM--(BUSINESS WIRE)--Regulatory news: Biotage (STO:BIOTA): Third quarter 2010
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Manufacturing
Pfizer Prepared to Reshore Manufacturing if Trump Makes Good on Tariff Threats
March 4, 2025
·
2 min read
·
Tristan Manalac
Podcast
A Conversation With Kevin Marks, CEO of Delphia
March 4, 2025
·
1 min read
·
Annalee Armstrong
NextGen
Delphia Eyes New Precision Medicine Approach: Activation Lethality
March 4, 2025
·
2 min read
·
Annalee Armstrong
Layoff Tracker
CRISPR, Cytiva Laying Off Employees
March 3, 2025
·
139 min read
·
BioSpace Editorial Staff
